Acute sinusitis in children: Current treatment strategies

Pediatric Drugs

Volumn 5, Issue 2, 2003, Pages 71-80

  Contopoulos Ioannidis, Despina G ^a,b   Ioannidis, John P A ^a,c   Lau, Joseph ^c  

^a UNIVERSITY OF IOANNINA   (Greece)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; AZITHROMYCIN; BRODIMOPRIM; CEFACLOR; CEFADROXIL; CEFPROZIL; CEFTIBUTEN; CEFUROXIME; CORTICOSTEROID; COTRIMAZINE; DECONGESTIVE AGENT; DOXYCYCLINE; ERYTHROMYCIN; PENICILLIN V; PIVAMPICILLIN; PLACEBO;

ACUTE DISEASE; ANTIBIOTIC RESISTANCE; COST EFFECTIVENESS ANALYSIS; COUGHING; DISEASE SEVERITY; DOSE RESPONSE; HUMAN; LAVAGE; NOSE DISEASE; PRIORITY JOURNAL; RADIOGRAPHY; REVIEW; RISK FACTOR; SINUSITIS; SYMPTOMATOLOGY; TREATMENT PLANNING;

EID: 0037278390     PISSN: 11745878     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128072-200305020-00001     Document Type: Review

References (51)

1. Gwaltney JM. Acute community-acquired sinusitis. Clin Infect Dis 1996; 23: 1209-23
2. Wald ER. Sinusitis in children. N Engl J Med 1992; 326: 319-23
3. Ioannidis JPA, Lau J. Technical report: evidence for the diagnosis and treatment of acute uncomplicated sinusitis in children: a systematic overview. American Academy of Pediatrics. Pediatrics 2002; 108: E57
4. Ficnar B, Huzjak N, Oreskovic K, et al. Azithromycin: 3-day versus 5-day course in the treatment of respiratory tract infections in children. Croatian Azithromycin Study Group. J Chemother 1997; 9: 38-43
5. Careddu P, Bellosta C, Tonelli P, et al. Efficacy and tolerability of brodimoprim in pediatric infections. J Chemother 1993; 5: 543-5
6. Wald ER, Reilly JS, Casselbrant M. et al. Treatment of acute maxillary sinusitis in childhood: a comparative study of amoxicillin and cefaclor. J Pediatr 1984; 104: 297-302
7. Wald ER, Chiponis D, Ledesma-Medina J. Comparative effectiveness of amoxicillin and amoxicillin-clavulanate potassium in acute paranasal sinus in fections in children: a double-blind, placebo-controlled trial. Pediatrics 1986; 77: 795-800
8. Jeppesen F, Illum P. Pivampicillin (pondocillin) in the treatment of maxillary sinusitis. Acta Otolaryngol 1972; 74: 375-82
9. Simon MW. A prospective randomized study comparing the efficacy of amoxicillin-clavulanate, erythromycin-sulfisoxazole, cefaclor, and cefprozil in treating acute sinusitis of childhood. Adv Ther 1997; 14: 64-72
10. Hager C, Bamberg P, Dom G, et al. The use of co-trimazine once daily in acute otitis media and maxillary sinusitis in children. J Int Med Res 1980; 8: 413-6
11. Helin I, Andreasson L, Jannert M, et al. Acute sinusitis in children: results of different therapeutic regimens. Helv Paediatr Acta 1982; 37: 83-8
12. Nylen O, Jeppsson PH, Branefors-Helander P. Acute sinusitis: a clinical bacteriological and serological study with special reference to Haemophilus influenzae. Scand J Infect Dis 1972; 4: 43-8
13. Gurses N, Kalayci AG, Islek I, et al. Cefuroxime axetil in the treatment of acute sinusitis in childhood. J Antimicrob Chemother 1996; 38: 547-50
14. Herz G, Gfeller J. Sinusitis in paediatrics. Chemotherapy 1977; 23: 50-7
15. Puhakka H, Virolainen E. Cefadroxil in the treatment of susceptible infections in infants and children. Drugs 1986; 32: 21-8
16. McLean DC. Sinusitis in children: lessons from twenty-five patients. Clin Pediatr (Phila) 1970; 9: 342-5
17. Aitken M, Taylor JA. Prevalence of clinical sinusitis in young children followed up by primary care pediatricians. Arch Pediatr Adolesc Med 1998; 152: 244-8
18. Ueda D, Yoto Y. The ten-day mark as a practical diagnostic approach for acute paranasal sinusitis in children. Pediatr Infect Dis J 1996; 15: 576-9
19. Revonta M, Suonpaa J. Diagnosis and follow-up of ultrasonographical sinus changes in children. Int J Pediatr Otorhinolaryngol 1982; 4: 301-8
20. McCormick DP, John SD, Swischuk LE, et al. A double-blind, placebo-controlled trial of decongestant-antihistamine for the treatment of sinusitis in children. Clin Pediatr (Phila) 1996; 35: 457-60
21. Barlan IB, Erkan E, Bakir M, et al. Intranasal budesonide spray as an adjunct to oral antibiotic therapy for acute sinusitis in children. Allergy Asthma Immunol 1997; 78: 598-601
22. Garbutt JM, Goldstein M, Gellman E, et al. A randomized, placebo-controlled trial of antimicrobial treatment for children with clinically diagnosed acute sinusitis. Pediatrics 2001; 107: 619-25
23. Simon MW. Treatment of acute sinusitis in childhood with ceftibuten. Clin Pediatr 1999; 38: 269-72
24. Yilmaz G, Varan B, Yilmaz T, et al. Intranasal budesonide spray as an adjunct to oral antibiotic therapy for acute sinusitis in children. Eur Arch Otorhinolaryngol 2000; 257: 256-9
25. Simon MW. Cefprozil vs amoxicillin in the treatment of childhood acute sinusitis. Int Pediatr 2000; 15: 93-6
26. Karadag A. Nasal saline for acute sinusitis [letter]. Pediatrics 2002; 109: 165
27. Mulrow CD, Linn WD, Gaul MK, et al. Assessing quality of a diagnostic test evaluation. J Gen Intern Med 1989; 4: 288-95
28. Garbutt JM, Gellman EF, Littenberg B. The development and validation of an instrument to assess acute sinus disease in children. Qual Life Res 1999; 8: 225-33
29. Sacco O, Tarantino V, Lantero S, et al. Nasal brusbing: a clinically useful procedure in pediatric patients with rhinosinusitis. Int J Pediatr Otorhinolaryngol 1999; 50: 23-30
30. Kogutt MS, Swischuk LE. Diagnosis of sinusitis in infants and children. Pediatrics 1973; 52: 121-4
31. Watt-Boolsen S, Karle A. The clinical use of radiological examination of the maxillary sinuses. Clin Otolaryngol 1977; 2: 41-3
32. Van Buchem FL, Peeters MF, Knottnerus JA. Maxillary sinusitis in children. Clin Otolaryngol 1992; 17: 49-53
33. Jannert M, Andreasson L, Helin I, et al. Acute sinusitis in children: symptoms, clinical findings and bacteriology related to initial radiologic appearance. Int J Pediatr Otorhinolaryngol 1982; 4: 139-48
34. Glasier CM, Mallory Jr GB, Steele RW. Significance of opacification of the maxillary and ethmoid sinuses in infants. J Pediatr 1989; 114: 45-50
35. Wald ER, Milmoe GJ, Bowen A, et al. Acute maxillary sinusitis in children. N Engl J Med 1981; 304: 749-54
36. McAlister WH, Parker BR, Kushner DC, et al. Sinusitis in the pediatric population. American College of Radiology ACR appropriateness criteria [online]. Available flora URL: http://www.acr.org/departments/appropriateness_criteria/toc.html [Accessed 2002 Nov 25]
37. Balk EM, Zucker DR, Engels EA, et al. Strategies for diagnosing and treating suspected acute bacterial sinusitis: a cost-effectiveness analysis. J Gen Intern Med 2001: 16: 701-11
38. American Academy of Pediatrics. Clinical practice guideline: management of sinusitis. Pediatrics 2001; 108: 798-808
39. Doem GV, Brueggemann AB, Pierce G, et al. Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995, and detection of beta-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study. Antimicrob Agents Chemother 1997; 41: 292-7
40. Dowell SF, Butler JC, Giebink GS, et al. Acute otitis media: management and surveillance in an era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus Pneumoniae Therapeutic Working Group. Pediatr Infect Dis J 1999; 18: 1-9
41. Harris SJ, Wald ER, Senior BA, et al. The sinusitis debate. Pediatrics 2002: 109: 166-7
42. de Ferranti SD, Ioannidis JP, Lau J, et al. Are amoxycillin and folate inhibitors as effective as other antibiotics for acute sinusitis: a meta-analysis. BMJ 1998; 317: 632-7
43. Ioannidis JP, Lau J. Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas. JAMA 2001; 285: 437-43
44. Ioannidis JP, Contopoulos-Ioannidis DG. Reporting of safety data from randomised trials. Lancet 1998; 352: 1752-3
45. Ioannidis JP, Chew P, Lau J. Standarized retrieval of side effects data for metaanalysis of safety outcomes: a feasibility study in acute sinusitis. J Clin Epidemiol 2002; 55: 619-26
46. Ioannidis JP, Contopoulos-Ioannidis DG, Chew P. et al. Meta-analysis of randomized controlled trials on the comparative efficacy and safety of azithromycin against other antibiotics for upper respiratory tract infections. J Antimicrob Chemother 2001; 48: 677-89
47. Takata GS, Chan LS, Shekelle P. et al. Evidence assessment of management of acute otitis media (I): the role of antibiotics in treatment of uncomplicated acute otitis media. Pediatrics 2001; 108: 239-47
48. Schrag SJ, Pena C, Fernandez J, et al. Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage: a randomized trial. JAMA 2001; 286: 49-56
49. Physician's desk reference (PDR). 57th ed. Medical Economics Company Inc. [online]. Available from URL: http://www.pdrnet.com [Accessed 2002 Nov 25]
50. Dagan R, Hoberman A, Johnson C, et al. Bacteriologic and clinical efficacy of high dose amoxicillin/clavulanate in children with acute otitis media. Pediatr Infect Dis J 2001; 20: 829-37
51. Bottenfield GW, Burch DJ, Hedrick JA, et al. Safety and tolerability of a new formulation (90 mg/kg/day divided every 12h) of amoxicillin/clavulanate (augmentin) in the empiric treatment of pediatric acute otitis media caused by drug-resistant Streptococcus pneumoniae. Pediatr Infect Dis J 1998: 17: 963-8